This evaluation assesses the degree of implementation of the EU Drugs Strategy 2013- 2020 and the Action Plan 2013-2016 in terms of outputs and, to the extent possible, impacts. It looks at the extent to which the objectives of the EU Drugs Strategy have been achieved, highlighting the areas...

This study aims to map alternatives to coercive sanctions (ACS) for drug law offences and drug-related crimes that are available under the law in each EU member state and describe the use of these sanctions in practice. This was complemented by a review of international research on the...

In accordance with the Better Regulation guidelines a mandatory public consultation was conducted to inform the Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and the final evaluation of the EU Action Plan on Drugs 2013-2016. The consultation was launched on 15 February 2016 on the...

This report provides the results from an analysis of characteristics and operations of the EU's illicit drugs market as called for by the European Commission. The study is a follow-up of the earlier European Commission study presenting an analysis of the developments of the global illicit drugs...

This document provides the key findings of a project assessing how the global market for drugs developed from 1998 to 2007 and describing drug policy around the globe during that period. To the extent data allows, the project assessed how much policy measures, at the national and sub-national...

This report presents a comparative analysis of drug problems and drug policies in a sample of eighteen countries over the period 1998 to 2007. It describes major changes and trends in individual countries and provides a comparison of countries. Domains examined include drug supply (production...